RFP QuestBeta
Awarded · ResultStage · contract

UK Health Security Agency

PHE - Corporate - Newborn Screening for Cystic Fibrosis

Government ServicesCPV 75000000 75100000 75120000
Value£100k
Awarded27 Aug 2021
Published4 Nov 2021
RegionUK-wide
Outcome — awarded

This is a contract result notice, not an open opportunity. Details from the official award data.

Contract value in context
£100ktotal contract value
median £400k
this tender£0£22.3m

This sits in the lower-middle of the Government & Public Administration band — a mid-scale opportunity. Based on 5,438 valued Government & Public Administration tenders in our corpus.

The brief

Determining the impact of employing next generation genomic sequencing (NGS) as part of the method of newborn screening for Cystic Fibrosis (CF): a stakeholder engagement project

Buyer intelligence

Make the case to bid

Reveal who to approach at UK Health Security Agency, and generate a go-to-market strategy from their news, accounts and people.

Source & provenance
OCID
e3b933cf-856b-4d2a-9daf-b7cb57f9696a
Stage
contract · Contract
Source
Contracts Finder
Buyer ref
CF-0451200D0O000000rwimUAA1
View the original notice on Contracts Finder

Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.

Market context

Who wins this kind of work

The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.

Top suppliers & buyers in Government & Public Administration

Scroll to explore the market network

UK Health Security Agency’s tender network

Assembling the network…